
Roflumilast for the Treatment of COPD in an Asian Population : A Randomized, Double-Blind, Parallel-Group Study
Keywords: ACROSS, A COPD Study Investigating Roflumilast on Safety and Effectiveness; AE, adverse event; ANCOVA, analysis of covariance; ICS, inhaled corticosteroid; LABA, long-acting β2 agonist; LAMA, long-acting muscarinic antagonist; OD, once daily; PDE4, phosph